| scholarly article | Q13442814 |
| P2093 | author name string | J Farley Ordovensky Staniec | |
| Natalie J Webb | |||
| P2860 | cites work | Infertility: from a personal to a public health problem. | Q33835652 |
| Cost-effective treatment for the couple with infertility | Q34095244 | ||
| Insurance coverage and outcomes of in vitro fertilization. | Q34146552 | ||
| A primary care approach to the infertile couple | Q34155858 | ||
| Funding in vitro fertilization treatment for persistent subfertility: the pain and the politics | Q34353325 | ||
| Success of intrauterine insemination in women aged 40-42 years | Q34719531 | ||
| Sex, lies, and health insurance: employer-provided health insurance coverage of abortion and infertility services and the ADA. | Q41120079 | ||
| Pathways to access: health insurance, the health care delivery system, and racial/ethnic disparities, 1996-1999. | Q47995169 | ||
| Practice patterns among reproductive endocrinologists: the infertility evaluation. | Q50963839 | ||
| The use of infertility services among fertility-impaired couples. | Q53873379 | ||
| Use of infertility services in the United States | Q64135717 | ||
| Predicting and optimizing success in an intra-uterine insemination programme | Q72574577 | ||
| Use of infertility services in the United States: 1995 | Q73998515 | ||
| Sample design, sampling weights, imputation, and variance estimation in the 1995 National Survey of Family Growth | Q74492071 | ||
| Cost-effective treatment of the infertile couple | Q77664342 | ||
| P433 | issue | 3 Pt 1 | |
| P304 | page(s) | 971-989 | |
| P577 | publication date | 2007-06-01 | |
| P1433 | published in | Health Services Research | Q5690687 |
| P1476 | title | Utilization of infertility services: how much does money matter? | |
| P478 | volume | 42 |
| Q36602084 | A New Way to Estimate the Potential Unmet Need for Infertility Services Among Women in the United States |
| Q82954086 | A cost per live birth comparison of HMG and rFSH randomized trials |
| Q38649801 | Affordability of Fertility Treatments and Multiple Births in the United States |
| Q42353131 | Clinical vignettes and global health considerations of infertility care in under-resourced patients |
| Q38074751 | Consequences of infertility in developing countries |
| Q43492973 | Cumulative incidence rate of medical consultation for fecundity problems--analysis of a prevalent cohort using competing risks |
| Q64109134 | Decision analysis about the cost-effectiveness of different in vitro fertilization-embryo transfer protocol under considering governments, hospitals, and patient |
| Q37630611 | Economics of assisted reproduction: access to fertility treatments and valuing live births in economic terms |
| Q28601036 | Ethical considerations for informed consent in infertility research: The use of electronic health records |
| Q47160564 | Fertility preservation of patients with testicular cancer |
| Q37270816 | Infertility evaluation and treatment among women in the United States. |
| Q35908838 | Infertility, fertility treatment, and risk of hypertension. |
| Q51125035 | Long-term fiscal implications of subsidizing in-vitro fertilization in Sweden: a lifetime tax perspective. |
| Q34084181 | Men who seek infertility care may not represent the general U.S. population: data from the National Survey of Family Growth |
| Q36581437 | Quebec public funding facilitates fertility preservation for male cancer patients |
| Q89584611 | Racial/Ethnic Differences in the Utilization of Infertility Services: A Focus on American Indian/Alaska Natives |
| Q34203901 | Similar DNA methylation levels in specific imprinting control regions in children conceived with and without assisted reproductive technology: a cross-sectional study |
| Q33913224 | Socioeconomic disparities in the use and success of fertility treatments: analysis of data from a prospective cohort in the United States. |
| Q31027428 | Supply of and demand for assisted reproductive technologies in the United States: clinic- and population-based data, 1995-2010. |
| Q38689633 | The Affordable Care Act and Assisted Reproductive Technology Use. |
| Q39674342 | The efficiency of a group-specific mandated benefit revisited: the effect of infertility mandates |
| Q37079136 | Time costs of fertility care: the hidden hardship of building a family |
| Q33700421 | Use of fertility treatment modalities in a large United States cohort of professional women. |
| Q50490839 | What can we learn from a decade of promoting safe embryo transfer practices? A comparative analysis of policies and outcomes in the UK and Australia, 2001-2010. |
| Q36858584 | Who receives a medical evaluation for infertility in the United States? |
| Q35040725 | Willingness to pay and conjoint analysis to determine women's preferences for ovarian stimulating hormones in the treatment of infertility in Spain |
Search more.